COMPASS PATHWAYS PLC Operating Income
COMPASS PATHWAYS PLC (CMPS) reported Operating Income of -$52.37 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-05
- COMPASS PATHWAYS PLC operating income (loss) for the quarter ending 2026-06-30 was -$52.37M.
- COMPASS PATHWAYS PLC operating income (loss) for the quarter ending 2026-03-31 was -$42.90M.
- COMPASS PATHWAYS PLC operating income (loss) for the quarter ending 2025-12-31 was -$45.95M.
- COMPASS PATHWAYS PLC operating income (loss) for the quarter ending 2025-09-30 was -$40.54M.
- COMPASS PATHWAYS PLC operating income (loss) for fiscal 2025 was -$179.04M.
- COMPASS PATHWAYS PLC operating income (loss) for fiscal 2024 was -$178.21M.
- COMPASS PATHWAYS PLC operating income (loss) for fiscal 2023 was -$136.92M.
- COMPASS PATHWAYS PLC operating income (loss) for fiscal 2022 was -$110.40M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$52.37M 10-Q · filed 2026-08-05 | -$95.28M 10-Q · filed 2026-08-05 | -$141.23M derived: sum of 3 quarters · filed 2026-08-05 | -$181.76M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$42.90M 10-Q · filed 2026-05-13 | -$88.86M derived: sum of 2 quarters · filed 2026-05-13 | -$129.39M derived: sum of 3 quarters · filed 2026-05-13 | -$172.32M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$45.95M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | -$86.49M derived: sum of 2 quarters · filed 2026-03-24 | -$129.42M derived: sum of 3 quarters · filed 2026-08-05 | -$179.04M 10-K · filed 2026-03-24 |
| 2025-09-30 | -$40.54M 10-Q · filed 2025-11-04 | -$83.47M derived: sum of 2 quarters · filed 2026-08-05 | -$133.09M 10-Q · filed 2025-11-04 | -$181.50M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$42.93M 10-Q · filed 2026-08-05 | -$92.55M 10-Q · filed 2026-08-05 | -$140.96M derived: sum of 3 quarters · filed 2026-08-05 | -$188.86M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$49.62M 10-Q · filed 2026-05-13 | -$98.03M derived: sum of 2 quarters · filed 2026-05-13 | -$145.93M derived: sum of 3 quarters · filed 2026-05-13 | -$189.25M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | -$48.41M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | -$96.31M derived: sum of 2 quarters · filed 2026-03-24 | -$139.63M derived: sum of 3 quarters · filed 2026-03-24 | -$178.21M 10-K · filed 2026-03-24 |
| 2024-09-30 | -$47.90M 10-Q · filed 2025-11-04 | -$91.22M derived: sum of 2 quarters · filed 2025-11-04 | -$129.79M 10-Q · filed 2025-11-04 | -$168.20M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | -$43.32M 10-Q · filed 2025-07-31 | -$81.89M 10-Q · filed 2025-07-31 | -$120.30M derived: sum of 3 quarters · filed 2025-07-31 | -$154.36M derived: sum of 4 quarters · filed 2025-07-31 |
| 2024-03-31 | -$38.57M 10-Q · filed 2025-05-08 | -$76.98M derived: sum of 2 quarters · filed 2025-05-08 | -$111.04M derived: sum of 3 quarters · filed 2025-05-08 | -$143.70M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | -$38.41M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$72.47M derived: sum of 2 quarters · filed 2025-02-27 | -$105.13M derived: sum of 3 quarters · filed 2025-02-27 | -$136.92M 10-K · filed 2025-02-27 |
| 2023-09-30 | -$34.06M 10-Q · filed 2024-10-31 | -$66.73M derived: sum of 2 quarters · filed 2024-10-31 | -$98.51M 10-Q · filed 2024-10-31 | -$130.71M derived: sum of 4 quarters · filed 2024-10-31 |
| 2023-06-30 | -$32.66M 10-Q · filed 2024-08-01 | -$64.45M 10-Q · filed 2024-08-01 | -$96.64M derived: sum of 3 quarters · filed 2024-08-01 | -$122.18M derived: sum of 4 quarters · filed 2024-08-01 |
| 2023-03-31 | -$31.79M 10-Q · filed 2024-05-08 | -$63.98M derived: sum of 2 quarters · filed 2024-05-08 | -$89.52M derived: sum of 3 quarters · filed 2024-05-08 | -$116.77M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | -$32.19M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$57.73M derived: sum of 2 quarters · filed 2024-02-29 | -$84.98M derived: sum of 3 quarters · filed 2024-02-29 | -$110.40M 10-K · filed 2024-02-29 |
| 2022-09-30 | -$25.54M 10-Q · filed 2023-11-02 | -$52.79M derived: sum of 2 quarters · filed 2023-11-02 | -$78.21M 10-Q · filed 2023-11-02 | -$106.53M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | -$27.26M 10-Q · filed 2023-08-03 | -$52.68M 10-Q · filed 2023-08-03 | -$81.00M derived: sum of 3 quarters · filed 2024-02-29 | -$102.77M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | -$25.42M 10-Q · filed 2023-05-11 | -$53.74M derived: sum of 2 quarters · filed 2024-02-29 | -$75.51M derived: sum of 3 quarters · filed 2024-02-29 | -$95.04M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | -$28.32M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$50.09M derived: sum of 2 quarters · filed 2024-02-29 | -$69.62M derived: sum of 3 quarters · filed 2024-02-29 | -$83.22M 10-K · filed 2024-02-29 |
| 2021-09-30 | -$21.77M 10-Q · filed 2022-11-03 | -$41.30M derived: sum of 2 quarters · filed 2022-11-03 | -$54.90M 10-Q · filed 2022-11-03 | -$66.42M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | -$19.53M 10-Q · filed 2022-08-04 | -$33.13M 10-Q · filed 2022-08-04 | -$44.65M derived: sum of 3 quarters · filed 2023-02-28 | -$58.13M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | -$13.60M 10-Q · filed 2022-05-10 | -$25.12M derived: sum of 2 quarters · filed 2023-02-28 | -$38.60M derived: sum of 3 quarters · filed 2023-02-28 | -$56.29M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | -$11.52M derived: 10-K 12 month − 6-K 9 month · filed 2023-02-28 | -$25.00M derived: sum of 2 quarters · filed 2023-02-28 | -$42.69M derived: sum of 3 quarters · filed 2023-02-28 | -$51.39M 10-K · filed 2023-02-28 |
| 2020-09-30 | -$13.48M 6-K · filed 2021-11-09 | -$31.17M derived: sum of 2 quarters · filed 2021-11-09 | -$39.87M 6-K · filed 2021-11-09 | |
| 2020-06-30 | -$17.69M 6-K · filed 2021-08-11 | -$26.39M 6-K · filed 2021-08-11 | ||
| 2019-12-31 | -$21.18M 10-K · filed 2022-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |